Quarterly report pursuant to Section 13 or 15(d)

Stockholder's Equity (Tables)

v3.10.0.1
Stockholder's Equity (Tables)
9 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Summary of Common Stock Shares Activity

The following table summarizes common stock share activity for the three and nine months ended September 30, 2018 and 2017 (dollars in thousands): 

 

 

 

Three Months Ended September 30, 3017

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, June 30, 2017

 

 

26,478,051

 

 

$

26

 

 

$

220,890

 

 

$

(189,260

)

 

$

31,656

 

Cumulative stock-based compensation forfeiture adjustment

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(8,401

)

 

 

(8,401

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

407

 

 

 

 

 

 

407

 

Common stock issued through employee stock purchase plan

 

 

10,465

 

 

 

 

 

 

18

 

 

 

 

 

 

18

 

Common stock issued, net of expenses

 

 

1,847,320

 

 

 

2

 

 

 

3,581

 

 

 

 

 

 

3,583

 

Balance, September 30, 2017

 

 

28,335,836

 

 

$

28

 

 

$

224,896

 

 

$

(197,660

)

 

$

27,264

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 3017

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, December 31, 2016

 

 

24,609,411

 

 

$

24

 

 

$

214,918

 

 

$

(180,123

)

 

$

34,819

 

Cumulative stock-based compensation forfeiture adjustment

 

 

 

 

 

 

 

 

67

 

 

 

(67

)

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(17,470

)

 

 

(17,470

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

1,241

 

 

 

 

 

 

1,241

 

Common stock issued through employee stock purchase plan

 

 

18,132

 

 

 

 

 

 

36

 

 

 

 

 

 

36

 

Common stock issued, net of expenses

 

 

3,708,293

 

 

 

4

 

 

 

8,634

 

 

 

 

 

 

8,638

 

Balance, September 30, 2017

 

 

28,335,836

 

 

$

28

 

 

$

224,896

 

 

$

(197,660

)

 

$

27,264

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 3018

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, June 30, 2018

 

 

46,844,072

 

 

$

47

 

 

$

246,517

 

 

$

(220,011

)

 

$

26,553

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

351

 

 

 

351

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

458

 

 

 

 

 

 

458

 

Common stock issued through employee stock purchase plan

 

 

17,770

 

 

 

 

 

 

21

 

 

 

 

 

 

21

 

Common stock issued, net of expenses

 

 

328,871

 

 

 

 

 

 

498

 

 

 

 

 

 

498

 

Common stock issued for vested restricted stock units

 

 

2,349

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Balance, September 30, 2018

 

 

47,193,062

 

 

$

47

 

 

$

247,492

 

 

$

(219,660

)

 

$

27,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 3018

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, December 31, 2017

 

 

28,971,651

 

 

$

29

 

 

$

226,631

 

 

$

(205,250

)

 

$

21,410

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(14,410

)

 

 

(14,410

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

1,351

 

 

 

 

 

 

1,351

 

Common stock issued through employee stock purchase plan

 

 

31,361

 

 

 

 

 

 

39

 

 

 

 

 

 

39

 

Common stock issued, net of expenses

 

 

18,181,064

 

 

 

18

 

 

 

19,480

 

 

 

 

 

 

19,498

 

Common stock issued for vested restricted stock units

 

 

8,986

 

 

 

 

 

 

(9

)

 

 

 

 

 

(9

)

Balance, September 30, 2018

 

 

47,193,062

 

 

$

47

 

 

$

247,492

 

 

$

(219,660

)

 

$

27,879

 

 

Common Stock Reserved For Future Issuances

The Company had reserved shares of common stock for future issuance as follows:

 

 

September 30, 2018

 

 

December 31, 2017

 

Outstanding stock options

 

4,110,108

 

 

 

3,075,994

 

Outstanding restricted stock units

 

107,841

 

 

 

64,365

 

Outstanding Series C-1 Preferred warrants

 

14,033

 

 

 

14,033

 

Warrants to purchase common stock associated with June 2016 Public Offering

 

4,218,750

 

 

 

4,218,750

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 1

 

13,198,075

 

 

 

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 2

 

7,988,175

 

 

 

 

Warrants to purchase common stock associated with Loan Agreement

 

122,435

 

 

 

122,435

 

For possible future issuance under 2014 Equity Incentive Plan (Note 9)

 

559,373

 

 

 

492,382

 

For possible future issuance under Employee Stock Purchase Plan (Note 9)

 

81,667

 

 

 

83,617

 

For possible future issuance under 2015 Inducement Plan (Note 9)

 

5,000

 

 

 

5,000

 

Total common shares reserved for future issuance

 

30,405,457

 

 

 

8,076,576